Postoperative Pain and Analgesic Use After Total Knee Arthroplasty
1 other identifier
observational
50
1 country
1
Brief Summary
This prospective observational study evaluates postoperative pain intensity and analgesic consumption in patients undergoing total knee arthroplasty (TKA) under different anesthesia techniques. Patients receive either general anesthesia with peripheral nerve block, spinal anesthesia with peripheral nerve block, spinal anesthesia alone, or general anesthesia with an epidural catheter. Pain scores (NRS), analgesic use, adverse effects, patient satisfaction, and the need for therapeutic interventions are assessed during the first 48 hours after surgery. The study aims to identify differences in postoperative pain control and factors associated with hypotension and other complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 24, 2026
CompletedStudy Start
First participant enrolled
March 1, 2026
CompletedFirst Posted
Study publicly available on registry
March 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 15, 2027
March 9, 2026
March 1, 2026
1 year
February 24, 2026
March 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative pain intensity
Pain intensity will be assessed using the Visual Analog Scale (VAS) or Numerical Rating Scale (NRS) at predefined postoperative intervals. Both scales range from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain imaginable. Higher scores represent worse pain intensity.
6 hours, 24 hours, and 48 hours after surgery
Secondary Outcomes (5)
Analgesic consumption
First 48 hours after surgery
Adverse effects
First 48 hours after surgery
Patient satisfaction
48 hours after surgery
Length of hospital stay
From the day of surgery (Day 0) through hospital discharge (typically 3-14 days).
Number of participants requiring therapeutic interventions
Up to 48 hours after surgery.
Study Arms (4)
General Anesthesia + Peripheral Nerve Block (CA + PNB)
Patients undergoing total knee arthroplasty under general anesthesia combined with a peripheral nerve block. General anesthesia is induced using intravenous and inhalational agents. A peripheral nerve block (most commonly femoral or saphenous) is administered preoperatively to reduce postoperative pain and opioid requirements. This group represents a commonly used multimodal analgesic approach in routine clinical practice.
General Anesthesia + Epidural Catheter (CA + EDA)
Patients undergoing total knee arthroplasty under general anesthesia with an epidural catheter placed for intraoperative and postoperative analgesia. General anesthesia is induced using intravenous and inhalational agents. The epidural catheter allows continuous administration of analgesics and individualized dose adjustment to maintain postoperative pain control. This group represents a commonly used technique for providing extended regional analgesia following TKA.
Spinal Anesthesia + Peripheral Nerve Block (SA + PNB)
Patients undergoing total knee arthroplasty under spinal anesthesia supplemented with a peripheral nerve block. Spinal anesthesia is administered into the subarachnoid space to provide intraoperative analgesia. A peripheral nerve block (femoral or saphenous) is added to enhance postoperative pain control and reduce the need for systemic analgesics. This combination represents a commonly used multimodal analgesic strategy.
Spinal Anesthesia (SA)
Patients receiving spinal anesthesia alone without an additional peripheral nerve block. Spinal anesthesia provides sensory and motor blockade of the lower body during surgery. This group allows evaluation of postoperative pain and analgesic requirements in patients managed with spinal anesthesia as the sole regional technique.
Eligibility Criteria
Adult patients aged 18-100 years undergoing primary total knee arthroplasty at Krajská nemocnice T. Bati, a. s. Patients must have ASA physical status I-III, GCS 15, ability to understand the study procedures, and provide informed consent. Only patients capable of cooperation during pre-anesthetic evaluation and without severe sensory impairment are included.
You may qualify if:
- Age 18-100 years
- Primary total knee arthroplasty (TKA)
- ASA physical status I-III
- Glasgow Coma Scale (GCS) score of 15
- Ability to understand study procedures and provide informed consent
- Ability to cooperate during pre-anesthetic evaluation
- No severe sensory impairment (e.g., blindness, deafness)
You may not qualify if:
- Revision or reoperation of TKA
- ASA score IV or higher
- Refusal to participate or inability to provide informed consent
- GCS ≤ 14
- Limited legal capacity
- Active psychiatric disorder
- Chronic use of strong opioid analgesics
- Neurological disease affecting pain perception or cooperation
- Cognitive impairment or language barrier preventing questionnaire completion
- Use of anesthesia techniques other than GA + PNB or SA + PNB (e.g., epidural anesthesia, local infiltration without PNB)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tomas Bata regional hospital
Zlín, 76001, Czechia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Research Lead, omas Bata Hospital
Study Record Dates
First Submitted
February 24, 2026
First Posted
March 9, 2026
Study Start
March 1, 2026
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
June 15, 2027
Last Updated
March 9, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
"Individual participant data will not be shared because the study involves sensitive clinical information and no data-sharing plan was included in the ethics committee approval. Data will be used exclusively for the purposes of this study."